-
Most Popular
Earnings Reports
IIIV Stock Earnings: i3 Verticals Misses EPS, Misses Revenue for Q3 2024
IIIV stock results show that i3 Verticals missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024.
APYX Stock Earnings: Apyx Medical Beats EPS, Beats Revenue for Q2 2024
APYX stock results show that Apyx Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
DXPE Stock Earnings: DXP Enterprises Beats EPS, Beats Revenue for Q2 2024
DXPE stock results show that DXP Enterprises beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SST Stock Earnings: System1 Beats EPS, Beats Revenue for Q2 2024
SST stock results show that System1 beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
CYTK Stock Earnings: Cytokinetics Misses EPS, Misses Revenue for Q2 2024
CYTK stock results show that Cytokinetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
OXBR Stock Earnings: Oxbridge Re Holdings Reported Results for Q2 2024
Oxbridge Re Holdings just reported results for the second quarter of 2024.
VXRT Stock Earnings: Vaxart Misses EPS, Beats Revenue for Q2 2024
VXRT stock results show that Vaxart missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
CMBM Stock Earnings: Cambium Networks Misses EPS, Misses Revenue for Q2 2024
CMBM stock results show that Cambium Networks missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
RCAT Stock Earnings: Red Cat Holdings Misses EPS, Misses Revenue for Q4 2024
RCAT stock results show that Red Cat Holdings missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2024.
LCTX Stock Earnings: Lineage Cell Therapeutics Beats EPS, Beats Revenue for Q2 2024
LCTX stock results show that Lineage Cell Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
XENE Stock Earnings: Xenon Pharmaceuticals Misses EPS for Q2 2024
XENE stock results show that Xenon Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
CUTR Stock Earnings: Cutera Misses EPS, Misses Revenue for Q2 2024
CUTR stock results show that Cutera missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
CCSI Stock Earnings: Consensus Cloud Solutions Beats EPS, Beats Revenue for Q2 2024
CCSI stock results show that Consensus Cloud Solutions beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
DNMR Stock Earnings: Danimer Scientific Beats EPS, Misses Revenue for Q2 2024
DNMR stock results show that Danimer Scientific beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024
COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
CARG Stock Earnings: CarGurus Beats EPS, Beats Revenue for Q2 2024
CARG stock results show that CarGurus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
HHS Stock Earnings: Harte-Hanks Misses EPS, Misses Revenue for Q2 2024
HHS stock results show that Harte-Hanks missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
BLFS Stock Earnings: BioLife Solns Beats EPS, Beats Revenue for Q2 2024
BLFS stock results show that BioLife Solns beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
